Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis

NCT00004402 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.

NCT NCT00004402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis
Lead sponsor
FDA Office of Orphan Products Development
Phase
Phase 3
Overall status
Completed
Start date
November 30, 1999
Completion date
June 30, 2000
Enrollment
30
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteopetrosis